Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
DRUGMAKER Merck & Co is in talks to acquire the biopharmaceuticals company Cubist for more than US$7 billion, according to people briefed on the matter.
The deal, if announced, would represent another multibillion-dollar health care transaction in a banner year for...